Paul Davies

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases

Martin Steger, Francesca Tonelli, Genta Ito et al. · eLife · 2016 · 1K citations · Full text

Mitophagy, Molecular Biology, Rab Gtpases +16

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

David E. Gordon, Joseph Hiatt, Mehdi Bouhaddou et al. · Science · 2020 · 794 citations · Full text

Viral Diagnostics, Covid-19 Pandemic, Viral Pathogenesis +12

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex^®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

Alena Novotná, Jan Mareš, S. Ratcliffe et al. · European Journal of Neurology · 2011 · 450 citations

Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2

Xianming Deng, Nicolas Dzamko, Alan R. Prescott et al. · Nature Chemical Biology · 2011 · 425 citations · Full text

Signal Transduction, Medicine, Receptor Tyrosine Kinase +6

Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosis

Christine Collin, Paul Davies, I. K. Mutiboko et al. · European Journal of Neurology · 2007 · 373 citations

Cannabis Use, Upon Spasticity, Controlled Trial +9